Double-blind placebo controlled study of the effects of etomidate-alfentanil anesthesia in electroconvulsive therapy

Journal of ECT

Volumn 20, Issue 2, 2004, Pages 107-111

  Van Den Broek, Walter W ^a   Groenland, Theo H N ^a   Kusuma, Arinardi ^a   Mulder, Paul G H ^b   Bruijn, Jan A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Alfentanil; Apnea; Brain; Cardiovascular system; Complications; Electroconvulsive therapy; Etomidate; Myoclonus; Seizures

Indexed keywords

ALFENTANIL; ETOMIDATE; PLACEBO;

ADULT; AGED; AGITATION; ANESTHESIA INDUCTION; APNEA; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CROSSOVER PROCEDURE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; HEART RATE; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INJECTION SITE; MALE; MEAN ARTERIAL PRESSURE; MYOCLONUS SEIZURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SEIZURE THRESHOLD; TACHYCARDIA;

ADULT; AGED; ALFENTANIL; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; ETOMIDATE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCLONUS; PLACEBOS; TACHYCARDIA;

EID: 2942525496     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200406000-00006     Document Type: Article

References (16)

1. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. (see comments) N Engl J Med. 1993;328:839-846.
2. Coffey CE, Lucke J, Weiner RD, et al. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry. 1995;37:713-720.
3. Wauquier A. Profile of etomidate. A hypnotic, anticonvulsant and brain protective compound. Anaesthesia. 1983;38(Suppl):26-33.
4. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596-602.
5. Christensen P, Kragh-Sorensen P, Sorensen C, et al. EEG-Monitored ECT: a comparison of seizure duration under anesthesia with etomidate and thiopentone. Convuls Ther. 1986;2:145-150.
6. Trzepacz PT, Weniger FC, Greenhouse J. Etomidate anesthesia increases seizure duration during ECT. A retrospective study. Gen Hosp Psychiatry. 1993;15:115-120.
7. Leentjens AF, van den Broek WW, Kusuma A, et al. Facilitation of ECT by intravenous administration of theophylline. Convuls Ther. 1996;12:232-237.
8. Nguyen TT, Chhibber AK, Lustik SJ, et al. Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br J Anaesth. 1997;79:801-803.
9. Miller DR, Martineau RJ, O'Brien H, et al. Effects of alfentanil on the hemodynamic and catecholamine response to tracheal intubation. Anesth Analg. 1993;76:1040-1046.
10. Williams E. Experimental designs balanced for the estimation of residual effects of treatments. Austr J Sci Res. 1949:149-168.
11. Wells DG, Zelcer J, Treadrae C. ECT-induced asystole from a subconvulsive shock. Anaesth Intensive Care. 1988;16:368-371.
12. Welch CA, Drop LJ. Cardiovascular Effects of ECT. Convuls Ther. 1989;5:35-43.
13. Cuche JL, Brochier P, Klioua N, et al. Conjugated catecholamines in human plasma: where are they coming from? J Lab Clin Med. 1990;116:681-686.
14. Spiss CK, Coraim F, Haider W, et al. Haemodynamic effects of fentanyl or alfentanil as adjuvants to etomidate for induction of anaesthesia in cardiac patients. Acta Anaesthesiol Scand. 1984;28:554-556.
15. Rucquoi M, Camu F. Cardiovascular responses to large doses of alfentanil and fentanyl. Br J Anaesth. 1983;55(Suppl 2):223S-230S.
16. Khalil SN, Howard G, Mankarious R, et al. Alfentanil decreases the excitatory phenomena of sodium methohexital. J Clin Anesth. 1998;10:469-473.